Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure.

Abstract

Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.